TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma-Reference-Cited by-同舟云学术

TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma

Published:2019-01-18 Issue:3 Volume:7 Page:355-362
ISSN:2326-6066
Container-title:Cancer Immunology Research
language:en
Short-container-title:Cancer Immunol Res

Author:

Josefsson Sarah E.,Beiske Klaus,Blaker Yngvild N.,Førsund Mette S.,Holte Harald^ORCID,Østenstad Bjørn,Kimby Eva,Köksal Hakan,Wälchli Sébastien^ORCID,Bai Baoyan,Smeland Erlend B.,Levy Ronald,Kolstad Arne,Huse Kanutte,Myklebust June H.

Funder

Research Council of Norway

Norwegian Cancer Society

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Immunology

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blockade of the TIGIT-CD155/CD112 axis enhances functionality of NK-92 but not cytokine-induced memory-like NK cells toward CD155-expressing acute myeloid leukemia;Cancer Immunology, Immunotherapy;2024-07-05

2. Quantification and Profiling of Early and Late Differentiation Stage T Cells in Mantle Cell Lymphoma Reveals Immunotherapeutic Targets in Subsets of Patients;Cancers;2024-06-21

3. Extended characterization of anti-CD19 CAR T cell products manufactured at the point of care using the CliniMACS Prodigy system: comparison of donor sources and process duration;Cytotherapy;2024-06

4. Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities;Signal Transduction and Targeted Therapy;2024-05-22

5. Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target;Blood Cancer Journal;2024-05-02